儿童与青少年风湿性心脏病:流行病学、发病机制与诊断
该综述综合儿童与青少年风湿热和风湿性心脏病的流行病学、发病机制、自然史及诊断证据,聚焦高疾病负担地区。超声心动图揭示大量临床沉默病变,更新版世界心脏联盟标准和WHO指南支持高危人群筛查与分期分类,早期检测结合二级抗生素预防可阻止早期病变进展。
要点
- 风湿性心脏病仍是全球儿童获得性心血管病主要原因,撒哈拉以南非洲、南亚、太平洋岛屿及高收入国家原住民和边缘人群中高发。
- 许多儿童在无明确风湿热发作情况下出现早期瓣膜病变,挑战传统线性病程认知,超声心动图可检出临床沉默病变。
- 更新版世界心脏联盟超声心动图标准和WHO指南支持高危人群筛查与分期分类,二级抗生素预防可阻止早期风湿性心脏病进展。
核心结论
- 风湿性心脏病是可预防的慢性病,具有可检测的早期阶段,早期检测结合二级抗生素预防可改善流行地区儿童与青少年结局。
研究设计与样本
- 综述综合儿童与青少年风湿热和风湿性心脏病的当代证据,聚焦高疾病负担地区。
主要发现
- 欧洲、北美和亚洲部分地区风湿热与风湿性心脏病显著减少,但撒哈拉以南非洲、南亚、太平洋岛屿及高收入国家原住民和边缘人群中患病率持续高。
- 高负担地区风湿热常发生于更小年龄,疾病进展加速,及时诊断和治疗可及性有限,导致显著发病和过早死亡。
- 发病机制模型支持A组链球菌感染后免疫介导的瓣膜损伤,咽部和皮肤感染均参与疾病启动,但个体易感性和进展机制尚未完全阐明。
- 近期观察和试验数据挑战传统线性范式,显示许多儿童无明确风湿热发作即出现早期瓣膜病变。
- 超声心动图揭示大量临床沉默病变负担,更新版世界心脏联盟超声心动图标准和近期WHO指南支持高危人群筛查和分期分类。
关键数值与推荐
- 更新版世界心脏联盟超声心动图标准支持高危人群筛查和风湿性心脏病分期分类。
- 近期WHO指南支持高危人群筛查和分期分类方法。
- 证据表明二级抗生素预防可阻止早期风湿性心脏病进展。
临床怎么用
- 在高风险人群中使用超声心动图筛查以早期识别临床沉默风湿性心脏病。
- 采用更新版世界心脏联盟超声心动图标准和WHO指南进行风湿性心脏病分期分类。
- 对早期风湿性心脏病患儿启动二级抗生素预防以阻止疾病进展。
局限性
- 个体易感性和从感染进展为慢性瓣膜损伤的机制仍未完全了解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rheumatic heart disease (RHD) remains a leading cause of acquired cardiovascular disease in children and adolescents globally, despite dramatic declines in high-income settings. This review synthesises contemporary evidence on the epidemiology, pathogenesis, natural history and diagnosis of rheumatic fever (RF) and RHD in young populations, with a focus on regions with high disease burden. Over recent decades, improvements in socio-economic conditions and access to healthcare have led to marked reductions in RF and RHD across much of Europe, North America and parts of Asia. In contrast, the disease persists at high prevalence in sub-Saharan Africa, South Asia, the Pacific Islands and among Indigenous and marginalised populations within high-income countries. In these settings, RF often occurs at younger ages, disease progression is accelerated and access to timely diagnosis and care is limited, resulting in substantial morbidity and premature mortality. Pathogenetic models continue to support immune-mediated valvular injury following Group A streptococcal infection, with increasing evidence that both pharyngeal and skin infections contribute to disease initiation. However, determinants of individual susceptibility and the mechanisms underlying progression from infection to chronic valvular damage remain incompletely understood. Importantly, recent observational and trial data challenge the traditional linear paradigm in which clinically apparent RF precedes RHD, demonstrating that many children develop early valvular disease without recognised RF episodes. Echocardiography has transformed the diagnosis of RHD, revealing a substantial burden of clinically silent disease and enabling earlier identification along the disease spectrum. Updated World Heart Federation echocardiographic criteria and recent WHO guidelines now support screening in high-risk populations and a staged approach to disease classification. Evidence that secondary antibiotic prophylaxis can prevent progression of early RHD reinforces the importance of early detection. Together, these advances reframe RHD as a preventable chronic disease with a detectable early phase, providing a strong foundation for effective prevention, timely diagnosis and improved outcomes in children and adolescents living in endemic regions.
引用
- BMJ Paediatrics Open:Rheumatic heart disease in children and adolescents, part 1: epidemiology, pathogenesis and diagnosis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。